BeiGene
Venture capitalChangping · Series A–Series B · 38 people tracked
Investment thesis
BeiGene (branded as BeOne) is a global biotechnology/pharmaceutical company that develops and commercializes cancer treatments and other medicines, not a venture capital investor.
Source: firm website, verified Aug 16, 2026.
Team · 38 people
from the firm's website
Frequently asked questions
- What stage does BeiGene invest at?
- BeiGene invests at the Series A, Series B stages.
- What sectors does BeiGene focus on?
- BeiGene focuses on Biotech, Healthtech.
- Where is BeiGene located?
- BeiGene is headquartered in Changping, CN.
Media · Podcasts & interviews
featuring the teamBeiGene CEO John V. Oyler's Welcome Remarks on BeiGene Virtual Congress Site
BeiGene · John V. Oyler
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.